Invasive Basal Cell Carcinoma of the Skin Treated Successfully with Vismodegib: A Case Report.
DISCUSSION: Although BCC is the most common skin cancer, it is usually a local disease and treated with local measures. Metastatic BCC is extremely rare, and in cases when surgical resection or local radiation are not viable options, chemotherapeutic agents typically offer very limited improvement. Vismodegib is an oral selective sonic hedgehog pathway inhibitor that shows benefit in patients with locally advanced or metastatic disease.
PMID: 30005721 [PubMed - in process]
Source: The Permanente journal - Category: General Medicine Tags: Perm J Source Type: research
More News: Basal Cell Carcinoma | Cancer | Cancer & Oncology | Carcinoma | CT Scan | General Medicine | Oral Cancer | PET Scan | Skin | Skin Biopsy | Skin Cancer